Product Name: Human Sclerostin Antibody (Romosozumab, Research Use)
Catalog Number: NBR-0280
Target Name: Sclerostin
Trade Name: Romosozumab
Antibody Drug Description: Romosozumab is a monoclonal antibody used to treat osteoporosis in postmenopausal women at high risk of fracture, patients who are intolerant of other treatments, or patients who have failed other treatments. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: Sclerostin
Synonyms: DAND6; VBC
Target Description: HMay be involved in the onset of endometrial receptivity for implantation/sensitization for the decidual cell reaction Enhances Wnt signaling and inhibits TGF-beta signaling (By similarity). Directly antagonizes activity of BMP2, BMP4, BMP6 and BMP7 in a dose-dependent manner.
Ensembl: ENSG00000167941
Uniprot: Q9BQB4